Pfizer's Phase 3 Success and GSK's Rollout Expansion Spark Momentum in the Global Malaria Vaccine Market

Global Malaria Vaccines market is expected to grow at a CAGR Of 31.85% during the forecast period 2024-2031.

The Malaria Vaccines Market develops preventive vaccines to reduce malaria burden caused by Plasmodium species. Growth is driven by high prevalence in Africa, Asia, and Latin America. RTS,S/AS01 and other candidates are advancing through clinical trials. Support from WHO, Gavi, and governments accelerates deployment. Vaccine adoption, combined with vector control, improves disease management. Pharmaceutical R&D focuses on long-lasting immunity and combination vaccines. Rising awareness and funding for malaria eradication strengthen market potential.

📌 Download Sample Report to Identify Emerging Deals & Opportunities in the Malaria Vaccines Market Landscape:- https://datamintelligence.com/download-sample/malaria-vaccines-market?Ranjith

☛ Malaria Vaccines Market Recent Developments 2025:

United States: Recent Industry Developments

✅ In July 2025, Pfizer announced positive Phase 3 results for its next-generation malaria vaccine, demonstrating enhanced efficacy in children under five in Sub-Saharan Africa.

✅ In June 2025, GSK expanded its RTS,S/AS01 malaria vaccine rollout in partnership with public health agencies, aiming to immunize millions of high-risk populations.

✅ In May 2025, Moderna initiated clinical trials for an mRNA-based malaria vaccine, leveraging rapid design and scalable production for global immunization programs.

Japan: Recent Industry Developments

✅ In July 2025, Takeda Pharmaceutical advanced adjuvanted malaria vaccine candidates targeting improved immunity and long-term protection in endemic regions.

✅ In June 2025, Shionogi & Co., Ltd. partnered with international research institutions to develop next-generation malaria vaccines using recombinant protein platforms.

✅ In May 2025, Daiichi Sankyo launched clinical evaluation of multi-strain malaria vaccines, focusing on broader coverage against Plasmodium falciparum and Plasmodium vivax.

☛ Malaria Vaccines Market Competitive Landscape:

GlaxoSmithKline Biologicals (GSK), the Swiss Serum Institute, WRAIR, Sanaria, BioNTech, Nobelpharma, CellFree Sciences, Sumaya Biotech, VLP Therapeutics LLC, Bharat Biotech, Serum Institute of India, Novavax, Kenya medical research institute.

Research Methodology

We follow a hybrid research approach, combining qualitative insights with rigorous quantitative analysis to deliver reliable and comprehensive market intelligence. Our process begins with extensive secondary research, drawing on trusted industry reports, proprietary databases, and credible market sources. This is then reinforced through targeted primary research, including structured surveys and in-depth interviews with industry leaders, subject matter experts, and key market participants.

📌 Request a Customized Market Report - Tailored insights to match your business goals: https://datamintelligence.com/customize/malaria-vaccines-market?Ranjith

☛ Segments Covered in the Malaria Vaccines Market:

By Type of Infectious Agents: Plasmodium Falciparum, Species of Anopheles, P. vivax, P. malaria, Others.

By Type of Vaccines: Erythrocytic, Pre erythrocytic, Multi antigen, Others.

By End User: Hospitals, Speciality Clinics, Retail Pharmacy, Others.

☛ This Report Includes:

✔ Comprehensive go-to-market strategies with actionable insights.

✔ Unbiased evaluation of overall market performance.

✔ Deep-dive analysis into development trends, competitive landscape, supply-demand dynamics, YoY growth, benchmarking, vendor mapping, market access, and overall progress.

✔ Tailored regional and country-level reports with detailed localized analysis available on request.

✔ Identification of niche segments and high-growth regions presenting strong opportunities.

✔ Accurate regional forecasts using both top-down and bottom-up approaches.

📌 Get Corporate Access to Live Malaria Vaccines Industry Intelligence Database: https://www.datamintelligence.com/buy-now-page?report=malaria-vaccines-market?Ranjith

☛ Regional Analysis for Malaria Vaccines Market:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

📌 Request for 2 Days FREE Trial Access: https://www.datamintelligence.com/reports-subscription

☛ Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring

☛ Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.